25th Annual Biotech in Europe Forum

FOR GLOBAL PARTNERING & INVESTMENT

8th - 9th of October 2025|MÖVENPICK HOTEL | BASEL | SWITZERLAND

Attendees:

2Lyora

3B Future Health Ventures

3i Group plc

4BIO Capital

7G BioVentures

AAA Family Office

AATec Medical GmbH

AbbVie

AbbVie Ventures

abcDNA GmbH

Ability Pharmaceuticals SA

AdBio Partners

AdCab (under University of Helsinki)

Adularia AG

AFK & Partners Asset Management LLC

AION Labs

Aixial Group

Alder Therapeutics AB

AlgenScribe SAS

Algiax Pharmaceuticals GmbH

Alkapharmics SARL

Allegro N.V.

ALSA Ventures

AltamarCAM Partners

Alzheimer's Drug Discovery Foundation

AM-Pharma B.V.

Ampleia

Amporin Pharmaceuticals AG

AMR Action Fund GP GmbH

Anaveon AG

Andera Partners SA

Angelini Ventures S.p.A.

APR Applied Pharma Research s.a.

Arc Health Inc.

ARCHIMED

Arcinova

ARENSIA Exploratory Medicine

Arivin Therapeutics Ltd.

Arphamid Therapeutics SAS

ARTCLINE GmbH

Ascension

Asian Innovation and Finance Center (AIFC)

Asklepios Advisors

Astr Partners

AstraZeneca

Avance Life Sciences

AVANTECA Partners AG

Awen GmbH

Baker McKenzie

BaseLaunch

Bayer AG

BB Biotech

Bellevue Asset Management AG

BeOne Medicines I GmbH

Bergmann zur Hausen & Cie. GmbH

Berlin Institute of Health at Charité (BIH)

BERNINA BioInvest Ltd.

BIOCELL LTD.

Biocytogen Pharmaceuticals (Beijing) Co.

BioGeneration Ventures

BioInnovation Institute

BioMedPartners AG

BioMedVC AG

Biopôle SA

Bioqube Ventures

BIOSTART Consulting GmbH

biotx.ai GmbH

BioXconomy

BirchBioMed Inc.

BlackRock

Bloomberg Intelligence

Bloomberg L.P.

Boehringer Ingelheim International GmbH

Boehringer Ingelheim Venture Fund GmbH

BOHE Angel Fund

Bootstrap Europe

Boyden Global Executive Search AG

Bpifrance

Brenus Pharma

Breslin AG

Brutkasten GmbH / VentureCapital Magazin

Business Angels Switzerland

Caedo Oncology

Cancer Research Horizons

Canton of Basel-Stadt

Capital Grand Est

CDP Venture Capital SGR S.p.A.

CDR-Life AG

Celex Oncology Innovations Limited

Cereno Scientific AB

Chromos Labs

Chugai Venture Fund

CIS BIOPHARMA AG

Claris Ventures

ClavystBio

ClearideBio Therapeutics AG

CNS Pharmaceuticals

Cohesion Bureau

Corinthian Financial Management SARL

Coulter Partners

Covington & Burling LLP

CPTx GmbH

Criteria Bio Ventures

Cube Labs SpA

Cue Biopharma

Cukierman & Co. Life Sciences

Cullgen Inc.

Curlim

Cytora

Davis Polk & Wardwell LLP

DCRM Sciences

DCVC Bio

DeBere Capital Partners

Debiopharm International SA

Delin Ventures

Desitin Arzneimittel GmbH

Diamante Società Benefit Srl

Digital Networks PLC

Dimericon Therapeutics AG

Disco Pharmaceuticals GmbH

docdok.health Ltd.

Droia Ventures

Eight Bridges

EIT Health e.V.

Elaia Partners

eleva GmbH

Eli Lilly and Company

Eliraz Ventures

Engimmune Therapeutics AG

ESC Advisors

European Investment Fund

Evernow Publishing Ltd

Evidenze

ExcellGene SA

F. Hoffmann-La Roche AG

FatiAbGen International GmbH

Finanz und Wirtschaft

Fine Treatment Limited

FINNCURE Ltd.

Flagship Pioneering

Flerie

Fontaine Capital

Forbion

Forty51 Ventures AG

FoRx Therapeutics AG

Fountain Healthcare Partners

FreeMind Group

Fund+

FundaMental Pharma GmbH

Galimedix Therapeutics

Genclis SA

Genesis Capital

Genius Search GmbH & Co. KG

Genmab A/S

GETEC PARK.SWISS AG

GIBF

Gilde Healthcare Partners B.V.

Gimv

GL Capital Group

GOLDTRACK Ventures GmbH

Grabulovski Consulting Services GmbH

GrayBella Capital

GSK

H. Lundbeck A/S

H.C. Wainwright & Co.

Hadasit Ltd.

HanchorBio Inc.

HBM Partners AG

HCRx

HealthCap

HEPHAISTOS Pharma

High-Tech Gründerfonds Management GmbH

Hikma Ventures

Hoba Therapeutics ApS

Hong Kong Exchanges and Clearing Limited (HKEX)

Hong Kong Trade Development Council

i3 Partners GmbH

ICF Consult Switzerland

ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

Immunethep

Indaco Venture Partners SGR S.p.A.

Industrifonden

InnoUp Farma

Innovestor Life Science Ltd.

Inotrem S.A.

Intermediate Capital Group PLC

InvestHK

IPF Partners

Ipsomel Innovations

Italian Angels for Growth (IAG)

JFG Life Sciences Stiftung der Universität Basel

JLP Health GmbH

JMI Capital Group

Johnson & Johnson Innovation LLC

KBI Biopharma

KdT Ventures

Kerna Ventures

KHAN Technology Transfer Fund

King Bioventures

KKR

Ksilink

Kurma Partners

Landmark BioVentures AG

Laverock Therapeutics Ltd.

Leads To Development

LifeCare Partners GmbH

LIfT BioSciences Ltd.

Limani Partners

LMU Munich

Loma Therapeutics

M&G Advisors GmbH

M2care

MC Services AG

Medicines Discovery Ventures

MEDiSTRAVA

Melio Bio

Memo Therapeutics AG

Merck KGaA

metaLead Therapeutics AG

Mighto Therapeutics

MitoRx Therapeutics

Mitsubishi Tanabe Pharma America

ModernVivo

Modi VC

Montis Biosciences BV

MSD

Nanolattix

NanoTherix

ND Capital

Neurochlore

New Science Fund

NG Bio Ltd

NLC Health Ventures

NodThera

Nomal Therapeutics

Noscendo GmbH

NoToVir Srl

Nouscom AG

Novac BiotechBD

Novartis AG

Novartis Pharma AG

Novartis Venture Fund

Novo Holdings A/S

NRW.Bank

NxR Biotechnologies GmbH

Olgram SAS

OmnilinX Therapeutics AG

Ona Therapeutics

Oncode Accelerator

Oncomatryx Biopharma S.L.

Oncovita

Onena Medicines AG

OphthaNova Therapeutics AG

Oppenheimer & Co. Inc.

Organos

Origenis GmbH

Orikine Bio

OrthoTreat

Oryzon Genomics

Otsuka America Pharmaceutical

Oxford Science Enterprises

OxSonics

Pace Ventures

palleos healthcare GmbH

Pappas Capital LLC

Pathios Therapeutics Limited

Perogative LLC

Perseo Pharma AG

Pharmaron UK Ltd

Pharmell Life Sciences SA

Pharming Group NV

Pilatus Biosciences SA

Platypus

Playground Global

Pleco Therapeutics BV

Pluvia Biotech

PMIC Advisors Group Ltd.

Primo Capital SGR S.p.A.

Procavea Biotech AG

Pureos Bioventures

Qualified Capital

QuantHealth

Recordati Pharma GmbH

RedHill Biopharma Ltd.

remynd NV

Roche Diagnostics

Ropes & Gray LLP

Rosetta Capital Ltd.

RV Invest

Ryvu Therapeutics

Salvina Therapeutics AG

Sanavia Oncology

Sanofi

SAPPIENS SAS

SCI Ventures LLC

Scius Communications

Secarna Pharmaceuticals GmbH & Co. KG

Selvita S.A.

Sen-Jam Pharmaceutical

Senya Therapeutics

Seqens

Serca Pharmaceuticals AS

Serenatis Bio

Seroba Life Sciences

Sherpa Healthcare Partners

SILREAL GmbH

SixPeaks Bio AG

Sobi

Sofinnova Investments

SOTIO Biotech a.s.

Sound Bioventures Management AB

SPARK Finland

Staatz BD & Strategy

Staatz Business Development & Strategy

STALICLA SA

Stifel

Strategic Transactions Advisory AG

Stromal Therapeutics AG

Sunstone Life Science Ventures

Superlab Suisse AG

Suterscience GmbH

Swiss Biotech Association

SWISS IMMUNE | Amedioo EDC

Swiss Investment Management SA

SynuCa Therapeutics

T-knife Therapeutics

TargImmune Therapeutics AG

Teitur Trophics ApS

Telomere Therapeutics

Tessara Therapeutics Pty Ltd.

The Fulford Group Ltd.

TheraVenture GmbH

TiVentures SA

TOLREMO Therapeutics AG

TransCure bioServices SAS

Tridek-One Therapeutics

Turbine Ltd.

UBS AG

UCEA Family Office

Umlaut.bio GmbH

University of Basel Innovation Office

University of Zurich

UPyTher B.V.

USI Startup Centre

V-Bio Ventures BV

Valor Management

Valpharma Group SpA

Vandria SA

Venture Valuation AG

Versant Ventures

Verve Ventures

Vesalius Biocapital IV Partners SàRL

Vesna Deeptech VC

VI Partners AG

VIB

Viopas Venture Consulting GmbH

Vogel BioC

VUS Genetics

Wellington Partners

Worldwide Clinical Trials

XGen Venture SGR S.p.A.

Xlife Sciences AG

YAYA Capital

Ysios Capital

Zinc VC

Last updated: November 17, 2025